■ We add Outperform-rated Santhera Pharmaceutical, Tecan, Rieter and Valora to our new high-conviction calls in the Swiss Small & Mid-Cap space.
■ We retain previous conviction calls of Outperform-rated Autoneum and Underperform-rated DKSH Holdings in our new list.
■ We remove, however, Outperform-rated Cosmo Pharmaceutical, OC Oerlikon and Straumann, as well as Not Rated EFG International.